Overexpression of miR-146a and miR-155 are Potentially Biomarkers and Predict Unfavorable Relationship between Gastric Cancer and Helicobacter pylori Infection.

Gastric Cancer (GC) is one of the most dangerous malignancies in the world. This study aims to evaluate the relationship between miR-146a and miR-155 in patients with infections with GC compared to -infected patients and healthy subjects. Forty patients with and GC positive diagnoses and 40 patients with positive and GC negative diagnoses, and 40 healthy persons were selected. The expression of miR-146a and miR-155 genes in the whole blood was examined using qRT-PCR. Moreover, ROC curves were drawn to represent the sensitivity and specificity of miR-146a and miR-155 expression as biomarkers. The results showed the expression of miR-146a and miR-155 in the whole blood of patients with and GC positive diagnoses are significantly higher than in healthy individuals and are non-significantly enhanced compared to positive and GC negative. Also, the results stated miR-146a and miR-155 expression in the whole blood of patients who are positive and GC negative are significantly increased compared to healthy individuals. Furthermore, the ROC curve analysis of miR-146a and miR-155 RNA level demonstrated the two miRNAs have an appropriate sensitivity and specificity for diagnostic goals. In conclusion, infection may increase the expression of miR-146a and miR-155 in patients with and GC positive diagnoses, which can be effective in the curbing the progression of GC. For this reason, up-regulation of miR-146a and miR-155 along with infection might contribute to the pathogenesis of GC, and also can be suggested as biomarkers for GC diagnosis and treatment.